Sharps Technology (NASDAQ:STSS) has reported its 2025 year-end results, revealing a comprehensive structural transformation from a medical device manufacturer into a digital asset-focused treasury holding company centered on the Solana ecosystem.
The company’s financial profile underwent a radical expansion in fiscal year 2025, with total assets surging to $269.1 million, up from just $7.3 million in the prior year.
This growth was fueled by over $430 million in capital raised during the fiscal year, which was strategically deployed into digital assets.
As of the year-end report, Sharps Technology holds more than 2 million SOL in its corporate treasury.
Approximately 95% of these holdings are currently staked, generating a gross yield of roughly 7%.
This shift in capital allocation has fundamentally altered the company's revenue mix; of the $7 million in total 2025 revenue, approximately $6.8 million was derived from staking rewards, while legacy product revenue accounted for just $204,000.
The transition has significantly de-leveraged the company’s balance sheet.
Stockholders’ equity rose to $264.4 million while total liabilities were slashed to $4.7 million.
Management confirmed that legacy manufacturing operations have been largely phased out to allow the firm to focus exclusively on digital asset staking, institutional partnerships, and strategic capital deployment within the blockchain sector.